Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ZBTB17 Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5103320
Description
Antibody detects endogenous levels of total ZBTB17.
Transcription factor that can function as an activator or repressor depending on its binding partners, and by targeting negative regulators of cell cycle progression. Plays a critical role in early lymphocyte development, where it is essential to prevent apoptosis in lymphoid precursors, allowing them to survive in response to IL7 and undergo proper lineage commitment. Has been shown to bind to the promoters of adenovirus major late protein and cyclin D1 and activate transcription. Required for early embryonic development during gastrulation.
Specifications
| ZBTB17 | |
| Polyclonal | |
| Unconjugated | |
| ZBTB17 | |
| AA589413; LP-1; Miz1; Miz-1; Myc-interacting zinc finger protein 1; Myc-interacting Zn finger protein-1; mZ13; pHZ-67; Polyomavirus late initiator promoter-binding protein; ZBTB17; Zfp100; Zfp-100; zinc finger and BTB domain containing 17; zinc finger and BTB domain-containing protein 17; Zinc finger protein 100; zinc finger protein 151; zinc finger protein 151 (pHZ-67); zinc finger protein 60; Zinc finger protein Z13; ZNF151; ZNF60 | |
| Rabbit | |
| Affinity chromatography | |
| RUO | |
| 22642, 313666, 7709 | |
| -20°C | |
| Liquid |
| Western Blot | |
| 1 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| Q13105, Q60821 | |
| ZBTB17 | |
| A synthesized peptide derived from human ZBTB17(Accession Q13105), corresponding to amino acid residues V195-A245. | |
| 100 μL | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction